Teleflex Incorporated

TFX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-905.6M $69.7M $356.3M $363.1M $485.4M $335.3M $461.5M $200.8M
Depreciation & Amortization $177.7M $161.5M $148.1M $230.6M $237.4M $227.3M $218.4M $214.7M
Depreciation $56.1M $52.8M $45.5M $66.5M $71.8M $68.6M $64.1M $60.5M
Amortization $121.7M $108.8M $102.6M $164.1M $165.6M $158.7M $150.0M $149.5M
Stock-Based Compensation $25.7M $26.0M $27.3M $27.2M $22.9M $20.7M $26.9M $22.4M
Net Cash from Operating Activities $96.7M $301.9M $206.1M $342.8M $652.1M $437.1M $437.1M $435.1M
Investing Activities
Capital Expenditures $95.2M $90.4M $46.4M $79.2M $71.6M $90.7M $102.7M $80.8M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — $156.7M $-837.8M $-73.5M $-196.4M
Financing Activities
Dividends Paid $60.3M $63.5M $63.9M $63.8M $63.6M $63.2M $62.8M $62.2M
Stock Repurchases $300.0M $200.0M $0 $0 — — — —
Net Cash from Financing Activities $611.5M $-421.9M $38.5M $-217.5M $-715.8M $455.2M $-418.8M $-206.4M
Net Change in Cash $126.2M $104.8M $-69.2M $-153.1M $69.2M $74.8M $-56.1M $23.6M
Free Cash Flow $1.4M $211.4M $159.7M $263.6M $580.5M $346.4M $334.4M $354.3M
← Newer Page 1 of 3 Older →